comprehensive -WSS

comprehensive

author：focus 2025-10-04 09:24:23 Page View：8

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： STAT Madness 2024: Meet the contenders
Next article： ChatGPT in medicine: STAT answers readers' burning questions

knowledge

How to save PrEP access — and even expand it

UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

STAT Virtual Event: JPM Recap, Live!

Editor’snote:Alivestreamoftheeventwillbeembeddedbelowat1p.m.ET.Relivethisyear’sJ.P.MorganHealthcareC

Medicare proposal to cover medical devices draws a mixed reaction

AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

5 ways to address the shortage of health care workers

Haltingandreversingthegrowingshortageofhealthcareworkerswillrequirecreativesolutionsandpartnerships.

comprehensive

explore

knowledge

5 ways to address the shortage of health care workers